{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:50:41Z","timestamp":1790272241052,"version":"4.1.0"},"reference-count":36,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T00:00:00Z","timestamp":1547942400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T00:00:00Z","timestamp":1547942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1111\/ane.13061","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T02:42:56Z","timestamp":1546828976000},"page":"369-376","source":"Crossref","is-referenced-by-count":48,"title":["Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain"],"prefix":"10.1155","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6288-9915","authenticated-orcid":false,"given":"Adam","family":"Strzelczyk","sequence":"first","affiliation":[{"name":"Department of Neurology, Epilepsy Center Frankfurt Rhine-Main; Goethe University; Frankfurt am Main Germany"},{"name":"Department of Neurology, Epilepsy Center Hessen; Philipps University; Marburg Germany"},{"name":"LOEWE Center for Personalized Translational Epilepsy Research (CePTER); Goethe University; Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Knake","sequence":"additional","affiliation":[{"name":"Department of Neurology, Epilepsy Center Hessen; Philipps University; Marburg Germany"},{"name":"LOEWE Center for Personalized Translational Epilepsy Research (CePTER); Goethe University; Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetta","family":"K\u00e4lvi\u00e4inen","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Eastern Finland; Kuopio Finland"},{"name":"Epilepsy Center\/Neuro Center; Kuopio University Hospital; Kuopio Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estevo","family":"Santamarina","sequence":"additional","affiliation":[{"name":"Epilepsy Unit; Hospital Vall d\u2019Hebron; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Toledo","sequence":"additional","affiliation":[{"name":"Epilepsy Unit; Hospital Vall d\u2019Hebron; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Willig","sequence":"additional","affiliation":[{"name":"Department of Neurology, Epilepsy Center Frankfurt Rhine-Main; Goethe University; Frankfurt am Main Germany"},{"name":"LOEWE Center for Personalized Translational Epilepsy Research (CePTER); Goethe University; Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Rohracher","sequence":"additional","affiliation":[{"name":"Department of Neurology, Christian Doppler Klinik; Paracelsus Medical University; Salzburg Austria"},{"name":"Centre for Cognitive Neuroscience; University of Salzburg; Salzburg Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Trinka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Christian Doppler Klinik; Paracelsus Medical University; Salzburg Austria"},{"name":"Centre for Cognitive Neuroscience; University of Salzburg; Salzburg Austria"},{"name":"Department of Public Health, Health Services Research and Health Technology Assessment; UMIT - University for Health Sciences, Medical Informatics and Technology; Hall in Tirol Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Rosenow","sequence":"additional","affiliation":[{"name":"Department of Neurology, Epilepsy Center Frankfurt Rhine-Main; Goethe University; Frankfurt am Main Germany"},{"name":"LOEWE Center for Personalized Translational Epilepsy Research (CePTER); Goethe University; Frankfurt am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,1,20]]},"reference":[{"key":"10.1111\/ane.13061-BIB0001|ane13061-cit-0001","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus-Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13061-BIB0002|ane13061-cit-0002","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/epi.13837","article-title":"Costs, length of stay, and mortality of super-refractory status epilepticus: a population-based study from Germany","volume":"58","author":"Strzelczyk","year":"2017","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13061-BIB0003|ane13061-cit-0003","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1517\/14656566.2016.1127354","article-title":"Pharmacologic treatment of status epilepticus","volume":"17","author":"Trinka","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/ane.13061-BIB0004|ane13061-cit-0004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1111\/ane.13061-BIB0005|ane13061-cit-0005","unstructured":"National Institute for Health and Care Excellence Epilepsies: diagnosis and management"},{"key":"10.1111\/ane.13061-BIB0006|ane13061-cit-0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1111\/ane.13061-BIB0007|ane13061-cit-0007","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","article-title":"25 years of advances in the definition, classification and treatment of status epilepticus","volume":"44","author":"Trinka","year":"2017","journal-title":"Seizure"},{"key":"10.1111\/ane.13061-BIB0008|ane13061-cit-0008","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1111\/ane.13061-BIB0009|ane13061-cit-0009","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"Holtkamp","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.13061-BIB0010|ane13061-cit-0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.13061-BIB0011|ane13061-cit-0011","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"key":"10.1111\/ane.13061-BIB0012|ane13061-cit-0012","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1528-1167.2009.02323.x","article-title":"Refractory status epilepticus: a prospective observational study","volume":"51","author":"Novy","year":"2010","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13061-BIB0013|ane13061-cit-0013","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","article-title":"Status epilepticus in adults","volume":"14","author":"Betjemann","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.13061-BIB0014|ane13061-cit-0014","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fneur.2017.00507","article-title":"Socioeconomic outcome and quality of life in adults after status epilepticus: a multicenter, longitudinal, matched case-control analysis from Germany","volume":"8","author":"Kortland","year":"2017","journal-title":"Front Neurol"},{"key":"10.1111\/ane.13061-BIB0015|ane13061-cit-0015","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/epi.14082","article-title":"The role of AMPA receptors and their antagonists in status epilepticus","volume":"59","author":"Leo","year":"2018","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13061-BIB0016|ane13061-cit-0016","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.13061-BIB0017|ane13061-cit-0017","doi-asserted-by":"crossref","first-page":"e00063","DOI":"10.1002\/prp2.63","article-title":"Effect of perampanel, a novel AMPA antagonist, on benzodiazepine-resistant status epilepticus in a lithium-pilocarpine rat model","volume":"2","author":"Hanada","year":"2014","journal-title":"Pharmacol Res Perspect"},{"key":"10.1111\/ane.13061-BIB0018|ane13061-cit-0018","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.eplepsyres.2017.06.002","article-title":"The neuroprotective effect of perampanel in lithium-pilocarpine rat seizure model","volume":"137","author":"Wu","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.13061-BIB0019|ane13061-cit-0019","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.yebeh.2015.01.036","article-title":"Efficacy of perampanel in refractory nonconvulsive status epilepticus and simple partial status epilepticus","volume":"45","author":"Redecker","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"Suppl 2","key":"10.1111\/ane.13061-BIB0020|ane13061-cit-0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/epi.14494","article-title":"Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: A single-center audit of 30 patients","volume":"59","author":"Rohracher","year":"2018","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13061-BIB0021|ane13061-cit-0021","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s13760-013-0225-3","article-title":"Possible effect of perampanel on focal status epilepticus after generalized tonic-clonic status epilepticus","volume":"114","author":"R\u00f6sche","year":"2014","journal-title":"Acta Neurol Belg"},{"key":"10.1111\/ane.13061-BIB0022|ane13061-cit-0022","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ebcr.2015.06.007","article-title":"Use of perampanel in one case of super-refractory hypoxic myoclonic status: Case report","volume":"4","author":"Santamarina","year":"2015","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1111\/ane.13061-BIB0023|ane13061-cit-0023","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.yebeh.2015.04.005","article-title":"Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit","volume":"49","author":"Rohracher","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.13061-BIB0024|ane13061-cit-0024","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.yebeh.2015.05.007","article-title":"Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus-approach to clinical application","volume":"49","author":"Leitinger","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.13061-BIB0025|ane13061-cit-0025","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00415-008-0989-1","article-title":"Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy","volume":"255","author":"Rossetti","year":"2008","journal-title":"J Neurol"},{"key":"10.1111\/ane.13061-BIB0026|ane13061-cit-0026","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12865","article-title":"The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist","volume":"56","author":"Patsalos","year":"2015","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13061-BIB0027|ane13061-cit-0027","unstructured":"ClinicalTrials.gov. Study to Evaluate Bioavailability of a Single 12 mg Dose of Perampanel for Three Intravenous Infusion Durations Relative to a Single 12 mg Perampanel Oral Tablet in Healthy Subjects Epub 2017 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03376997"},{"key":"10.1111\/ane.13061-BIB0028|ane13061-cit-0028","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ebcr.2016.05.001","article-title":"Add-on perampanel in Lance-Adams syndrome","volume":"6","author":"Steinhoff","year":"2016","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1111\/ane.13061-BIB0029|ane13061-cit-0029","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/epi.13716","article-title":"Lacosamide in status epilepticus: Systematic review of current evidence","volume":"58","author":"Strzelczyk","year":"2017","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13061-BIB0030|ane13061-cit-0030","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/ane.12174","article-title":"Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus","volume":"129","author":"Kellinghaus","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.13061-BIB0031|ane13061-cit-0031","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yebeh.2017.03.028","article-title":"Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals","volume":"70","author":"Strzelczyk","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"Suppl 2","key":"10.1111\/ane.13061-BIB0032|ane13061-cit-0032","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/epi.14486","article-title":"Intravenous brivaracetam in status epilepticus: A retrospective single-center study","volume":"59","author":"Kalss","year":"2018","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1111\/ane.13061-BIB0033|ane13061-cit-0033","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/epi.14480","article-title":"Intravenous ketamine in status epilepticus","volume":"59","author":"H\u00f6fler","year":"2018","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13061-BIB0034|ane13061-cit-0034","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40263-016-0371-2","article-title":"(S)-Ketamine in refractory and super-refractory status epilepticus: a retrospective study","volume":"30","author":"H\u00f6fler","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1111\/ane.13061-BIB0035|ane13061-cit-0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ane.12403","article-title":"Stiripentol for the treatment of super-refractory status epilepticus","volume":"132","author":"Strzelczyk","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.13061-BIB0036|ane13061-cit-0036","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jnnp.2005.080887","article-title":"Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation","volume":"77","author":"Rossetti","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.13061","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.13061\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:47:05Z","timestamp":1671540425000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.13061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,20]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.13061","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,20]]}}}